Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

November 01, 1991; Volume 259,Issue 2
  • You have access
    Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma x rat glioma hybrid cell line NG108-15.
    A Georg and A Friedl
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 479-483;
  • You have access
    Inhibitory action of peripheral-type benzodiazepines on dopamine release from PC12 pheochromocytoma cells.
    M Ohara-Imaizumi, K Nakazawa, T Obama, K Fujimori, A Takanaka and K Inoue
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 484-489;
  • You have access
    Effects of guanidino compounds on the endothelium-derived relaxing factor inhibitor NG-monomethyl L-arginine.
    G Thomas and P W Ramwell
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 490-494;
  • You have access
    Cocaine-induced elevation of plasma adrenocorticotropin hormone and corticosterone is mediated by serotonergic neurons.
    A D Levy, Q A Li, J E Kerr, P A Rittenhouse, G Milonas, T M Cabrera, G Battaglia, M C Alvarez Sanz and L D Van de Kar
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 495-500;
  • You have access
    Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis.
    M D Linnik, B T Butler, R R Gaddis and N K Ahmed
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 501-507;
  • You have access
    Inhibition of adenylate cyclase attenuates adenosine receptor-mediated relaxation in coronary artery.
    M H Sabouni, D J Cushing, S R Makujina and S J Mustafa
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 508-512;
  • You have access
    Existence of ATP-evoked ATP release system in smooth muscles.
    T Katsuragi, T Tokunaga, S Ogawa, O Soejima, C Sato and T Furukawa
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 513-518;
  • You have access
    Vascular nitric oxide-generating activities for organic nitrites and organic nitrates are distinct.
    E A Kowaluk and H L Fung
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 519-525;
  • You have access
    Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
    C Borg, S Mondot, M Mestre and I Cavero
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 526-534;
  • You have access
    Rate-dependent effects of lidocaine on His-Purkinje conduction in the intact neonatal heart--characterization and amplification by N-acetylprocainamide.
    T L Dise, A Stolfi, C W Clarkson and A S Pickoff
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 535-542;
  • You have access
    Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand.
    T P Su, X Z Wu, E J Cone, K Shukla, T M Gund, A L Dodge and D W Parish
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 543-550;
  • You have access
    Not norepinephrine but its oxidation products bind specifically to plasma proteins.
    F Boomsma, A J Man in 't Veld and M A Schalekamp
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 551-557;
  • You have access
    Electrophysiological actions of BRB-I-28 in canine myocardial tissues.
    E Patterson, B J Scherlag, K D Berlin and R Lazzara
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 558-565;
  • You have access
    Characterization of sulfonylurea receptors and the action of potassium channel openers on cholinergic neurotransmission in guinea pig isolated small intestine.
    S Zini, Y Ben-Ari and M L Ashford
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 566-573;
  • You have access
    Cocaine differentially affects benzodiazepine receptors in discrete regions of the rat brain: persistence and potential mechanisms mediating these effects.
    N E Goeders
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 574-581;
  • You have access
    Increased analgesic potency of mu agonists after continuous naloxone infusion in rats.
    C A Paronis and S G Holtzman
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 582-589;
  • You have access
    Release of platelet activating factor by the isolated kidney is not linked to the production of prostaglandins.
    A S Nies, A Tunney, A Barden, M Sturm and R Vandongen
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 590-594;
  • You have access
    D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey.
    J D Elsworth, M S Lawrence, R H Roth, J R Taylor, R B Mailman, D E Nichols, M H Lewis and D E Redmond
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 595-600;
  • You have access
    Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors.
    J H Miller, V A Gibson and M McKinney
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 601-607;
  • You have access
    Dynorphin-induced depression of the dorsal root potential in rat spinal cord: a possible mechanism for potentiation of the C-fiber reflex.
    P Stewart and L Isaac
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 608-613;
  • You have access
    Diurnal variation of the rat vas deferens contraction induced by stimulation of presynaptic nicotinic receptors and pineal function.
    R C Carneiro, J Cipolla-Neto and R P Markus
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 614-619;
  • You have access
    Facilitated transport of cefodizime into the rat central nervous system.
    H Matsushita, H Suzuki, Y Sugiyama, Y Sawada, T Iga, Y Kawaguchi and M Hanano
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 620-625;
  • You have access
    1,10-bis(guanidino)decane inhibits N-methyl-D-aspartate responses in vitro and in vivo.
    I J Reynolds, B M Baron and M L Edwards
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 626-632;
  • You have access
    Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates.
    C A Broomfield, D M Maxwell, R P Solana, C A Castro, A V Finger and D E Lenz
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 633-638;
  • You have access
    Vascular actions of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries.
    G Rubanyi, A Iqbal, A Schwartz and P M Vanhoutte
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 639-642;
  • You have access
    Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.
    J P Hieble, A C Sulpizio, R Edwards, H Chapman, P Young, S P Roberts, T P Blackburn, M D Wood, D H Shah and R M Demarinis
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 643-652;
  • You have access
    Antagonism of norepinephrine by clonidine in the isolated rat mesenteric vascular bed.
    J Q Kong, D A Taylor and W W Fleming
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 653-658;
  • You have access
    Characterization of bradykinin mediating pertussis toxin-insensitive biphasic response in circular muscle of the isolated guinea pig ileum.
    J B Calixto and Y S Medeiros
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 659-665;
  • You have access
    Vanadate potentiates hypoxic pulmonary vasoconstriction.
    N F Voelkel and J Czartolomna
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 666-672;
  • You have access
    Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. I. Analysis of agonist sensitivity.
    M C Olianas and P Onali
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 673-679;
  • You have access
    Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. II. Characterization of the antagonist sensitivity and comparison with muscarinic inhibitions of the enzyme in striatum and heart.
    M C Olianas and P Onali
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 680-686;
  • You have access
    Comparison of inhibitory potency by nonpeptide angiotensin II receptor antagonists PD123177 and DuP 753 on proximal nephron and renal transport.
    M G Cogan, F Y Liu, P C Wong and P B Timmermans
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 687-691;
  • You have access
    Presynaptic facilitation of dopamine release through D,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors on synaptosomes from the rat striatum.
    J M Desce, G Godeheu, T Galli, F Artaud, A Chéramy and J Glowinski
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 692-698;
  • You have access
    Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus.
    D W Hein, T D Rustan, K D Bucher and L S Miller
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 699-704;
  • You have access
    Calcium currents and peptide release from neurohypophysial terminals are inhibited by ethanol.
    X M Wang, G Dayanithi, J R Lemos, J J Nordmann and S N Treistman
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 705-711;
  • You have access
    Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.
    M K James, P L Feldman, S V Schuster, J M Bilotta, M F Brackeen and H J Leighton
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 712-718;
  • You have access
    Location of penetration and metabolic barriers to levobunolol in the corneal epithelium of the pigmented rabbit.
    P Ashton, W Wang and V H Lee
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 719-724;
  • You have access
    Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    E J Drower, A Stapelfeld, M F Rafferty, B R de Costa, K C Rice and D L Hammond
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 725-731;
  • You have access
    Cardiac effects of beta-2 adrenoceptor stimulation with intracoronary procaterol in the absence and presence of regional myocardial ischemia in dogs.
    K Noguchi, Y Ojiri, T Chibana, H Moromizato and M Sakanashi
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 732-737;
  • You have access
    A new type of vasodilator, HA1077, an isoquinoline derivative, inhibits proliferation of bovine vascular smooth muscle cells in culture.
    M Shirotani, Y Yui, R Hattori and C Kawai
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 738-744;
  • You have access
    Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus.
    M Starec, B Rouveix, M Sinet, F Chau, B Desforges, J J Pocidalo and P Lechat
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 745-750;
  • You have access
    Pharmacologic actions of Ro 24-5913, a novel antagonist of leukotriene D4.
    M O'Donnell, H J Crowley, B Yaremko, N O'Neill and A F Welton
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 751-758;
  • You have access
    Arachidonic acid and bradykinin share a common pathway to release neuropeptide from capsaicin-sensitive sensory nerve fibers of the guinea pig heart.
    P Geppetti, E Del Bianco, M Tramontana, T Vigano, G C Folco, C A Maggi, S Manzini and M Fanciullacci
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 759-765;
  • You have access
    Renal selective N-acetyl-L-gamma-glutamyl prodrugs. III. N-acetyl-L-gamma-glutamyl-4'-aminowarfarin is not targeted to the kidney but is selectively excreted into the bile.
    J C Drieman and H H Thijssen
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 766-771;
  • You have access
    Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    E A Walker, T Yamamoto, P J Hollingsworth, C B Smith and J H Woods
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 772-782;
  • You have access
    Reduction of cardiac outward currents by alpha-1 adrenoceptor stimulation: a subtype-specific effect?
    X L Wang, E Wettwer, G Gross and U Ravens
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 783-788;
  • You have access
    Influence of debrisoquine phenotype and of quinidine on mexiletine disposition in man.
    J Turgeon, C Fiset, R Giguère, M Gilbert, K Moerike, J R Rouleau, H K Kroemer, M Eichelbaum, O Grech-Bélanger and P M Bélanger
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 789-798;
  • You have access
    Comparative pharmacology of the nitrobenzylthioguanosine-sensitive and -resistant nucleoside transport mechanisms of Ehrlich ascites tumor cells.
    J R Hammond
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 799-807;
  • You have access
    Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans.
    R M Maiorino, R C Dart, D E Carter and H V Aposhian
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 808-814;
  • You have access
    Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.
    K Miyata, T Kamato, M Yamano, A Nishida, H Ito, Y Katsuyama, H Yuki, R Tsutsumi, M Ohta and M Takeda
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 815-819;
  • You have access
    Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
    J F Nash and J Brodkin
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 820-825;
  • You have access
    Effect of ketoconazole on methylprednisolone pharmacokinetics and receptor/gene-mediated pharmacodynamics.
    D B Haughey and W J Jusko
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 826-832;
  • You have access
    Serotoninergic involvement in ethanol-induced alterations of thermoregulation in long-sleep and short-sleep mice.
    T A French and N Weiner
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 833-840;
  • You have access
    Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.
    G Engberg, T Elebring and H Nissbrandt
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 841-847;
  • You have access
    Comparison of the behavioral and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist.
    E MacDonald, M Scheinin, H Scheinin and R Virtanen
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 848-854;
  • You have access
    Effect of alkaline pH on taxol-microtubule interactions.
    I Ringel and S B Horwitz
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 855-860;
  • You have access
    Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
    P C Wong, S D Hart, A T Chiu, W F Herblin, D J Carini, R D Smith, R R Wexler and P B Timmermans
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 861-870;
  • You have access
    Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    J Weissenburger, J M Davy, F Chézalviel, O Ertzbischoff, J M Poirier, F Engel, P Lainée, E Penin, G Motté and G Cheymol
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 871-883;
  • You have access
    Electrophysiological effects of sodium channel blockers on guinea pig left atrium.
    T Shirayama, D Inoue, M Inoue, T Tatsumi, Y Yamahara, J Asayama, H Katsume and M Nakagawa
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 884-893;
  • You have access
    Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome.
    D Deschamps, C Fisch, B Fromenty, A Berson, C Degott and D Pessayre
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 894-904;
  • You have access
    Systemic vascular effects of cyclosporin A treatment in normotensive rats.
    A Rego, R Vargas, S Cathapermal, M Kuwahara, M L Foegh and P W Ramwell
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 905-915;
  • You have access
    Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region.
    J D Steketee and P W Kalivas
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 916-924;
  • You have access
    Methylxanthine treatment of smooth muscle cells differentially modulates adenylate cyclase responsiveness.
    C J Stille and G L Stiles
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 925-931;
  • You have access
    Hyperpolarization of denervated skeletal muscle by lemakalim and its antagonism by glybenclamide and tolbutamide.
    S J Hong and C C Chang
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 932-938;
  • You have access
    Actions of intravenous magnesium on ventricular arrhythmias caused by acute myocardial infarction.
    S Nattel, N Turmel, R Macleod and B C Solymoss
    Journal of Pharmacology and Experimental Therapeutics November 1991, 259 (2) 939-946;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 259, Issue 2
1 Nov 1991
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • SEP-363856, a Novel, Non-D2 Psychotropic Agent
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics